The table below shows Bolt Biotherapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$7.70M
$7.69M
$7.88M
$5.73M
$1.26M
$231.00K
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$28.53M
$57.47M
$61.54M
$73.12M
$75.66M
$40.36M
SG&A
$13.79M
BOLT annual revenue (10-K history)
Bolt Biotherapeutics, Inc. reported annual revenue of $7.70M for fiscal year 2025. That is up 0.1% from $7.69M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $231.00K (FY 2020) to $7.70M. Figures come from the company's audited annual reports as filed with the SEC.